House Rejects Medical Marijuana Testing Bill, Leaving Future Oversight in Limbo Maine’s push to tighten oversight of its medical marijuana market has stalled after the House overwhelmingly rejected a key testing and tracking bill, LD 1847. The proposal, authored by Rep. Anne Graham, D-Newport, would have required batch testing and product tracking for medical cannabis,
READ MORE
How You Consume Cannabis Can Change Everything From vape pens to nanoemulsion drinks, how you take cannabis can dramatically shape your high — and the science says it is pharmacology, not preference, that drives the difference. Inhaled cannabis sends THC from the lungs to the bloodstream within seconds, producing rapid effects that usually fade within
READ MORE
Texas Adds Three Conditional Licensees as Medical Cannabis Program Grows Texas is moving to expand its tightly regulated medical cannabis market, with three additional businesses advancing in the state licensing process. The Department of Public Safety (DPS) announced it has entered Phase II of the Texas Compassionate Use Program expansion, conditionally selecting GTI Texas LLC
READ MORE
A new preclinical study suggests full-spectrum cannabis oil could help reverse key markers of fatty liver disease, at least in an animal model. Researchers examined metabolic dysfunction-associated steatotic liver disease (MASLD) in female Wistar rats fed a sucrose-rich diet, then treated them with an oral cannabis oil containing cannabidiol (CBD) and THC in a 2:1
READ MORE
medical cannabis, marking a cautious but significant shift in the state’s long-running marijuana debate. Legislative Bill 933, sponsored by Sen. John Cavanaugh, cleared its first hurdle in a 30–7 vote and would bar criminal, civil or disciplinary penalties solely for issuing a written recommendation when a provider believes cannabis benefits outweigh risks. Amendments adopted with
READ MORE
core symptoms of autism in children, in what developers say could be a world first if successful. The Monash Health study will recruit 150 Victorian children with autism spectrum disorder, who will receive either a placebo or twice-daily drops of the CBDA‑rich oil, which contains only low doses of THC. Earlier pilot and Phase 2
READ MORE
